Virginie Éclache

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Claude Preudhomme, Joëlle Guilhot, Franck E. Nicolini et al. · New England Journal of Medicine · 2010 · 386 citations

Pharmacy, Hematology, Pharmacotherapy +6

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas et al. · Blood · 2019 · 237 citations · Full text

Life Sciences, Hematology, Oncology +16

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

Cécile Bally, Lionel Adès, Aline Renneville et al. · Leukemia Research · 2014 · 159 citations

Medicine, Molecular Genetics, Oncology +17

Treatment of adult systemic mastocytosis with interferon‐α: results of a multicentre phase II trial on 20 patients

Philippe Casassus, Nadine Caillat‐Vigneron, Antoine Martin et al. · British Journal of Haematology · 2002 · 158 citations

Life Sciences, Immunology, Pharmacotherapy +14

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

Sylvain Thépot, Raphaël Itzykson, Valérie Seegers et al. · Blood · 2010 · 156 citations

Medicine, Hematology, Oncology +17